The Role of Chemotherapy in Advanced Cancer of the Head and Neck. A Review of Eighty Cases
1963

Chemotherapy for Advanced Head and Neck Cancer

Sample size: 80 publication Evidence: moderate

Author Information

Author(s): D. F. N. Harrison, W. N. Tucker

Primary Institution: Royal National Throat Nose and Ear Hospital

Hypothesis

Can chemotherapy improve the prognosis for patients with advanced cancer of the head and neck?

Conclusion

Chemotherapy using ethoglucid and cyclophosphamide can provide significant relief and even complete regression of tumors in some patients with advanced head and neck cancer.

Supporting Evidence

  • 84% of the cases were squamous carcinomata.
  • 32% of patients showed no improvement, while 30% experienced symptomatic relief.
  • 12% of patients had complete regression of their tumors.

Takeaway

Doctors tried two medicines to help people with really bad throat and neck cancer, and some got better, even though it was very hard to treat.

Methodology

Eighty patients with advanced head and neck cancer were treated with two cytotoxic agents, ethoglucid and cyclophosphamide, from September 1961 to September 1963.

Potential Biases

Selection bias may exist as all patients had previously failed other treatments.

Limitations

The study does not provide long-term follow-up data and the sample includes patients who had previously received other treatments.

Participant Demographics

Patients ranged in age from 14 months to 82 years, with a majority over 60 years old.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication